Physician profile
Steven Smith
NPI 1841289972
$672.57
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $170 · 2022: $37.50.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $324.22 | 2019 | |
| Novo Nordisk INC | $63.18 | 2019-2022 | |
| Lilly USA, LLC | $47.20 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $39.92 | 2019 | |
| Amgen INC. | $28.71 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.77 | 2020 | |
| Glaxosmithkline, LLC. | $24.18 | 2020 | |
| Allergan, INC. | $19.00 | 2019 | |
| Astellas Pharma US INC | $18.54 | 2019 | |
| Pfizer INC. | $16.49 | 2020 | |
| Boston Scientific Corporation | $14.15 | 2022 | |
| Currax Pharmaceuticals LLC | $13.72 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.89 | 2020 | |
| Indivior INC. | $11.44 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Research and ownership
$56,919.20 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.